Literature DB >> 33230034

Vision loss and hallucinations: perspectives from neurology and ophthalmology.

Ali G Hamedani1.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to summarize the evidence for visual impairment as a risk factor for visual hallucinations in neurologic disease and recent advances in our understanding of the central visual pathways that mediate this association. RECENT
FINDINGS: Recent studies have described the prevalence Charles Bonnet syndrome and questioned its lack of association with cognitive impairment, used advanced neuroimaging to show that disinhibition of the occipital lobe is involved in the pathogenesis of visual hallucinations in Parkinson's disease, and demonstrated that visual impairment because of eye disease is a consistent risk factor for visual hallucinations across a number of different neurodegenerative disease populations.
SUMMARY: Through connections between the primary visual cortex and other brain structures, visual function is closely tied to visual hallucinations. Given that the vast majority of vision loss is caused by ophthalmic disease, much of which is preventable or treatable, the detection and treatment of vision loss in at-risk populations may reduce the burden and consequences of visual hallucinations in older adults.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33230034     DOI: 10.1097/WCO.0000000000000882

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  1 in total

1.  Medicare Claims Data Underestimate Hallucinations in Older Adults With Dementia.

Authors:  Ali G Hamedani; Daniel Weintraub; Allison W Willis
Journal:  Am J Geriatr Psychiatry       Date:  2021-08-05       Impact factor: 4.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.